Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI

Clinical trial NCT01895829 · TERMINATED

Trial details

NCT number: NCT01895829
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2013-09-12
Primary completion: 2021-09-07
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.